For the two billion people without access to healthcare, growing interest from the world's pharmaceutical companies is potentially good news.
Stanford's Social Innovation Review, however, has a short and sweet answer to the logical resulting question of how these companies might reach the next two billion - and it's one that won't sound familiar on business terms:
"Money alone is not an easy route to access innovation and new markets. A more engaged, partnership-based approach is required."
Stanford's Social Innovation Review, however, has a short and sweet answer to the logical resulting question of how these companies might reach the next two billion - and it's one that won't sound familiar on business terms:
"Money alone is not an easy route to access innovation and new markets. A more engaged, partnership-based approach is required."
No comments:
Post a Comment